(株)メドレックスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4586/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2013/07/05 | 日証協 | 101,800株 | -43.41% | 0株 | -100% | 92,953株 | -36.2% | 16,711株 | -75.29% |
2013/06/28 | 日証協 | 179,900株 | -19.79% | 22,100株 | -79.61% | 145,705株 | -6.8% | 67,640株 | +22.98% |
2013/06/21 | 日証協 | 224,300株 | +73.47% | 108,400株 | +533.92% | 156,342株 | +47.02% | 55,000株 | +113.82% |
2013/06/14 | 日証協 | 129,300株 | +2.38% | 17,100株 | +1121.43% | 106,341株 | -2.73% | 25,722株 | +9.88% |
2013/06/07 | 日証協 | 126,300株 | +0.4% | 1,400株 | -75% | 109,326株 | +11.31% | 23,410株 | +44.48% |
2013/05/31 | 日証協 | 125,800株 | 0% | 5,600株 | -20% | 98,220株 | +2.4% | 16,203株 | -24.67% |
2013/05/24 | 日証協 | 125,800株 | -20.68% | 7,000株 | -79.29% | 95,917株 | -16.74% | 21,509株 | -30.63% |
2013/05/17 | 日証協 | 158,600株 | -2.94% | 33,800株 | +990.32% | 115,208株 | +13.95% | 31,005株 | +6.18% |
2013/05/10 | 日証協 | 163,400株 | -2.8% | 3,100株 | -43.64% | 101,107株 | -4.89% | 29,201株 | +411.4% |
2013/05/02 | 日証協 | 168,100株 | -4.43% | 5,500株 | -93.41% | 106,307株 | +1.63% | 5,710株 | -87.64% |
2013/04/26 | 日証協 | 175,900株 | -31.26% | 83,500株 | -29.89% | 104,607株 | -30.31% | 46,200株 | +2100% |
2013/04/19 | 日証協 | 255,900株 | +11.8% | 119,100株 | +264.22% | 150,107株 | -5.07% | 2,100株 | -91.03% |
2013/04/12 | 日証協 | 228,900株 | +0.22% | 32,700株 | +87.93% | 158,120株 | +0.44% | 23,400株 | +33.71% |
2013/04/05 | 日証協 | 228,400株 | -30% | 17,400株 | -87.16% | 157,420株 | +0.96% | 17,500株 | -8.85% |
2013/03/29 | 日証協 | 326,300株 | +170.12% | 135,500株 | +38.83% | 155,920株 | -58.21% | 19,200株 | +140% |
2013/03/22 | 日証協 | 120,800株 | -44.99% | 97,600株 | +1500% | 373,120株 | +161.24% | 8,000株 | -43.33% |
2013/03/15 | 日証協 | 219,600株 | -0.86% | 6,100株 | +134.62% | 142,828株 | -72.03% | 14,117株 | -54.02% |
2013/03/08 | 日証協 | 221,500株 | +57.99% | 2,600株 | -97.76% | 510,612株 | -0.97% | 30,702株 | -28.44% |
2013/03/01 | 日証協 | 140,200株 | +43.06% | 116,200株 | -17.06% | 515,612株 | +16.89% | 42,901株 | -74.03% |
※株式分割は考慮していませんのでご注意ください。
Page Top